Results 101 to 110 of about 179,970 (275)
International Journal of Women's HealthSongfeng Zhao,1,2 Xin Pan1,2 1Department of Endocrinology, The First People’s Hospital of Xiaoshan District, Hangzhou, Zhejiang, People’s Republic of China; 2Department of Endocrinology, Xiaoshan Affiliated Hospital of Wenzhou Medical University ...
Zhao S, Pan X
doaj
Deciphering epigenetic regulation in postmenopausal osteoporosis: Current and future perspectives
ViewPostmenopausal osteoporosis is the most prevalent form of osteoporosis, affecting approximately 33% of postmenopausal women globally and representing a major cause of age‐related disability and mortality.
Xiumei Tang +10 more
doaj +1 more source
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
Experimental and Molecular Medicine, 2018 Osteoporosis: protein trigger for postmenopausal bone loss identified A protein that helps trigger bone loss in postmenopausal osteoporosis could be a potential therapeutic target.
Joo-Hee Choi +6 more
doaj +1 more source
The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
, 2002 The aim of this study was to compare the efficacy of continuous and intermittent salmon calcitonin in the treatment of postmenopausal osteoporosis. Sixty-eight women with postmenopausal osteoporosis were randomized to 2 treatment groups. The first group
F. Taşçıoğlu, C. Öner, O. Armağan
core
Estimating the prevalence of osteoporosis in Australia [PDF]
, 2014 This report presents information about the prevalence and impact of osteoporosis in Australians aged 50 and over. Summary Osteoporosis, a common condition among older people, causes bones to become weak.
core
A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis [PDF]
Osteoporosis is a major cause of morbidity, mortality and resource cost amongst the elderly population. Hip fracture is the most serious of the osteoporotic fractures, with approximately 10-20% of patients dying within six months of sustaining a fracture.
Bernie O'Brien +3 more
core
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions
, 2001 Assessing the cost-effectiveness of long-term treatment for osteoporosis requires use of mathematical models to estimate health effects and costs for competing interventions.
Adachi, J D, +5 more
core +1 more source
Journal of the American Geriatrics Society, EarlyView.Conceptual framework illustrating the hypothesized association between hearing loss and frailty, including the confounders and effect measure modifiers evaluated in this study. ABSTRACT Objective To examine the association between objectively measured hearing ability and frailty using the accumulation of deficits model in adults aged ≥ 65 years and ...
Cora Leigh White +5 more
wiley +1 more source
Medicine ScienceOsteoporosis is a prevalent skeletal disorder characterized by decreased bone mineral density and an increased risk of fractures, particularly in postmenopausal women.
Kenan Bentli, Can Demirel
doaj +1 more source
, 2006 Aim: The aim of this study was to compare the efficacy of risendronate and raloxifene treatments on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal osteoporosis.
Cengiz Öner +4 more
core